Nextgen Biotech

Call us:

Doceaqualip 20mg - Docetaxel Lipid Suspension For Injuction

Doceaqualip 20mg is a Docetaxel Lipid Suspension Injection used in the treatment of various cancers, including breast cancer, lung cancer, prostate cancer, stomach cancer, and head & neck cancer. It works by inhibiting cancer cell division and preventing tumor growth, making it an effective chemotherapy agent.

Select your size:

Choose Quantity:

-
+
Share
General Information:
Generic Name: Docetaxel Lipid Suspension
Brand Name: Doceaqualip
Packing: Vial
Strength: 20 mg
Manufacturer: Intas Pharmaceuticals Ltd.
Form: Intravenous Injection
Category: Chemotherapy / Antineoplastic Agent / Taxane Derivative
Product Introduction:
Doceaqualip 20mg is a lipid-based formulation of Docetaxel, a taxane chemotherapy drug used in the treatment of solid tumors. This formulation enhances drug stability and reduces toxicity, offering an alternative for patients intolerant to solvent-based Docetaxel. It is administered as an intravenous infusion under medical supervision.

Uses of Doceaqualip 20mg Injection:
Doceaqualip 20mg is used to treat the following cancers:
  1. Breast Cancer – Used alone or in combination with other drugs for advanced/metastatic breast cancer.
  2. Non-Small Cell Lung Cancer (NSCLC) – Effective in advanced-stage lung cancer treatment.
  3. Prostate Cancer – Treats metastatic hormone-refractory prostate cancer.
  4. Gastric (Stomach) Cancer – Used in combination therapy for advanced gastric cancer.
  5. Head & Neck Cancer – Used in chemotherapy regimens for squamous cell carcinoma.
  6. Ovarian Cancer (Off-label use) – Sometimes used in cases resistant to first-line therapy.

Storage Instructions:
  1. Store at 2°C – 8°C (refrigerator temperature).
  2. Do not freeze or expose to high temperatures.
  3. Keep in original packaging to protect from light.
  4. Shake well before use if required.
  5. Discard any unused portion as per medical guidelines.

How Doceaqualip 20mg Works (Mechanism of Action):
Docetaxel is a microtubule inhibitor that:
  1. Prevents cancer cell division – Disrupts the microtubules required for cell division, causing cell death.
  2. Enhances apoptosis (programmed cell death) – Forces cancer cells to undergo self-destruction.
  3. Inhibits angiogenesis – Prevents blood vessel formation in tumors, reducing their growth potential.
This lipid-based formulation improves drug solubility and reduces toxicity, offering a better safety profile than conventional Docetaxel.

Side Effects:
Common Side Effects:
  1. Fatigue and weakness
  2. Nausea and vomiting
  3. Hair loss (Alopecia)
  4. Low blood cell count (neutropenia, anemia, thrombocytopenia)
  5. Loss of appetite
  6. Peripheral neuropathy (numbness or tingling)
  7. Skin rash or nail discoloration
Severe Side Effects (Rare but Serious):
  1. Severe allergic reactions (rash, swelling, difficulty breathing)
  2. Febrile neutropenia (low white blood cells with fever, high infection risk)
  3. Severe liver toxicity (jaundice, elevated liver enzymes)
  4. Severe fluid retention (swelling in limbs, lung congestion)
  5. Severe neuropathy (persistent nerve damage)
Immediate medical attention is required for severe side effects.

Dosage (Typical Recommended Dose):
Standard Chemotherapy Dosage (Varies by Cancer Type):
  1. Breast Cancer / Lung Cancer / Stomach Cancer / Head & Neck Cancer:
    1. 75–100 mg/m² IV infusion every 3 weeks, often with pre-medications.
  2. Prostate Cancer:
    1. 75 mg/m² IV infusion every 3 weeks + Prednisone.
  3. Lower Dosages for High-Risk Patients:
    1. 60 mg/m² IV infusion in elderly or weak patients.
Dosing adjustments are made based on patient condition, body surface area (BSA), and blood test results.

Method of Administration:
  1. Given as an intravenous (IV) infusion over 1 hour.
  2. Administered in a hospital/clinic by an oncologist or trained nurse.
  3. Pre-medication with corticosteroids (e.g., Dexamethasone) is recommended to reduce allergic reactions and fluid retention.
  4. Hydration and blood tests are required before each cycle.

Precautions:
  1. Pre-medications (corticosteroids) reduce the risk of severe side effects.
  2. Regular blood tests are required to monitor white blood cells and liver function.
  3. Avoid live vaccines during treatment.
  4. Use contraception (for both men and women) during and 6 months after treatment.
  5. Not recommended in pregnancy or breastfeeding.
  6. Patients with liver disease require dose adjustments or close monitoring.

Drug Interactions:
Doceaqualip 20mg may interact with:
  1. CYP3A4 inhibitors (Ketoconazole, Ritonavir, Clarithromycin) – Increases Docetaxel toxicity.
  2. CYP3A4 inducers (Rifampin, Carbamazepine, Phenytoin) – Reduces Docetaxel effectiveness.
  3. Warfarin & Blood Thinners – Increases bleeding risk.
  4. Other Chemotherapy Drugs (Cisplatin, Doxorubicin, Capecitabine) – Requires careful dose adjustments.
  5. Live Vaccines – Weakened immunity may lead to severe infections.
Inform your doctor about all medications you are taking.

Allergies (Warnings for Allergic Reactions):
  1. Avoid if allergic to Docetaxel or lipid-based formulations.
  2. Symptoms of an allergic reaction: rash, swelling, difficulty breathing, dizziness.
  3. Pre-medication with corticosteroids is required to prevent severe reactions.

Overdose Information:
Symptoms of Overdose:
  1. Severe low blood cell counts (neutropenia, anemia, thrombocytopenia)
  2. Severe nausea, vomiting, and diarrhea
  3. Organ failure (kidney/liver damage)
  4. Severe allergic reaction or breathing difficulty
What to do in case of overdose?
  1. Seek immediate medical attention.
  2. Supportive care with IV fluids, blood transfusion, and medications to control toxicity.

Missed Dose Instructions:
  1. If a dose is missed, the doctor will reschedule the next infusion.
  2. Do not self-administer or double the dose.
  3. Maintain regular follow-ups to avoid treatment delays.

Additional Notes:
  1. Hydration is important to prevent kidney damage.
  2. Patients should follow a neutropenic diet to avoid infections.
  3. Regular liver function tests are required.
  4. Hair loss is temporary and will recover after treatment.
View More

In The Same Category

Cart